Once-versus Twice-weekly Bortezomib Induction Therapy with Dexamethasone in Newly Diagnosed Multiple

• 作 者: 王雅丹 艾利莎 崔国惠 Bhuveshwarnath Gow
• 机 构: InstituteofHematology
• 出 处: 华中科技大学学报：医学英德文版
• 发表日期: 2012年4期
• 关键词: BORTEZOMIB multiple MYELOMA WEEKLY schedule response rate ADVERSE event Bortezom

In this study,we administered a modified schedule of weekly intravenous Bortezomib at 1.6 mg/m 2 with dexamethasone(BD) and compared it to the standard 1.3 mg/m 2 twice-weekly BD regimen in Chinese patients with newly diagnosed multiple myeloma(MM).We ass